riboflavins Search Results


94
Santa Cruz Biotechnology riboflavin
Riboflavin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pm41503892-327-0-4?v=Santa+Cruz+Biotechnology
Average 94 stars, based on 1 article reviews
riboflavin - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Toronto Research Chemicals riboflavin-13c,15n2
Riboflavin 13c,15n2, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc09684086-311-26-35?v=Toronto+Research+Chemicals
Average 90 stars, based on 1 article reviews
riboflavin-13c,15n2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
Thermo Fisher riboflavin
Riboflavin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/10__1590_slash_s0103___50532011000100005-41-15-19?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
riboflavin - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Thermo Fisher acros organics 232930050 riboflavin alfa aesar a11764 riboflavin
Acros Organics 232930050 Riboflavin Alfa Aesar A11764 Riboflavin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc06770930__nutrients___11___01971___s001-14-170--1?v=Thermo+Fisher
Average 93 stars, based on 1 article reviews
acros organics 232930050 riboflavin alfa aesar a11764 riboflavin - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology rfk
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Rfk, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc12572645-349-6-7?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
rfk - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Thermo Fisher fmn na
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Fmn Na, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc09263134-181-10-11?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
fmn na - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology riboflavin 5 monophosphate sodium salt
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Riboflavin 5 Monophosphate Sodium Salt, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc06356222-97-0-5?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
riboflavin 5 monophosphate sodium salt - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
Valiant Co Ltd roseoflavin
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Roseoflavin, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc03754745-101-0-4?v=Valiant+Co+Ltd
Average 90 stars, based on 1 article reviews
roseoflavin - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

91
BOC Sciences riboflavin
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Riboflavin, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc09038046-67-0-6?v=BOC+Sciences
Average 91 stars, based on 1 article reviews
riboflavin - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

90
Valiant Co Ltd riboflavin5 phosphate
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Riboflavin5 Phosphate, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/10__1097_slash_ico__0000000000000743-42-0-4?v=Valiant+Co+Ltd
Average 90 stars, based on 1 article reviews
riboflavin5 phosphate - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

91
Boster Bio antibodies against caspase 1
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Antibodies Against Caspase 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pm31241987-86-11-16?v=Boster+Bio
Average 91 stars, based on 1 article reviews
antibodies against caspase 1 - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

90
Biosynth Carbosynth riboflavin
a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of <t>RFK</t> (sh RFK ) <t>or</t> <t>FADS</t> (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.
Riboflavin, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/riboflavins/pmc04200291-180-17-24?v=Biosynth+Carbosynth
Average 90 stars, based on 1 article reviews
riboflavin - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of RFK (sh RFK ) or FADS (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: FAD synthase confers ferroptosis resistance and restrains CD8 + T cell recruitment in hepatocellular carcinoma

doi: 10.1038/s41467-025-64572-y

Figure Lengend Snippet: a Comparisons of VB2 metabolism scores between tumors and non-tumor livers from TCGA-LIHC, OEP000321, and ICGC-LIRI-JP datasets. Scores were calculated for each sample using the ssGSEA algorithm based on a VB2 metabolism gene signature. b Kaplan-Meier overall survival curves stratified by VB2 metabolism scores, with optimal cutoffs determined by the surv_cutpoint function. c t-SNE visualization showing 7 major cell types in tumor samples from the immunotherapy cohort ( n = 8). d Proportions of the 7 major cell types across the eight patients. e Box plots with medians (red line) and interquartile ranges depicting VB2 metabolism scores in various cell types. Scores were calculated with the AUCell algorithm based on the VB2 metabolism gene signature. f UMAP plot showing 12 major cell types in the GSE202642 dataset. g Violin plot showing VB2 metabolism scores among tumor cells and normal epithelial cells in GSE202642 . h Schematic diagram of the VB2 metabolic pathway with metabolites in black and enzymes in red. i Hep3B and HCCLM3 cells treated with VB2 (10 µM), FMN (10 µM), FAD (10 µM), or PBS (Ctrl) for 48 h, followed by CCK-8 assay ( n = 5 biological replicates). j Subcutaneous tumors were established in Rag1 -/- mice with Hepa1-6 cells ( n = 5 per group). Mice received daily intratumoral injections of VB2 (50 mg/kg) or control solvent from day 5 to day 21. Tumor volumes were measured at the indicated timepoints. Tumors were photographed and weighed at day 21. k Proliferation of Hep3B and HCCLM3 cells with lentiviral knockdown of RFK (sh RFK ) or FADS (sh FLAD1 ) ( n = 5 biological replicates), as determined by CCK-8 assay and colony formation assay. l Migration of HCCLM3 cells with RFK or FADS knockdown, assessed by transwell assay ( n = 3 biological replicates). For bar graphs, data are presented as mean ± SD ( i – k ). For box plots ( a , e ), the box shows the median with interquartile ranges (IQR), whiskers extend to 1.5 × IQR, and outliers are shown as individual points. P- values were calculated using one-way ANOVA with Tukey’s test ( i , k ), two-way ANOVA with Tukey’s test ( j , k ), unpaired two-sided Student’s t test ( j ), two-sided Wilcoxon rank-sum test ( a , e , g ), and log-rank test ( b ). Source data are provided as a Source Data file.

Article Snippet: Antibody information: β-actin (CST, #4970, 1:1000), RFK (Santa Cruz, #sc-398830, 1:500), FADS (Proteintech, #68491-1-Ig, 1:5000), PCBP2 (ABclonal, #A23987, 1:2000), FLAG-tag (ABclonal, #AE005, 1:10000), His-tag (ABclonal, #AE003, 1:5000), HA-tag (ABclonal, #AE008, 1:2000), USP10 (Proteintech, #19374-1-AP, 1:1000), cGAS (Proteintech, #26416-1-AP, 1:2000), STING (Proteintech, #80365-RR, 1:1000), TBK1 (CST, #3504, 1:1000), phospho-TBK1 (CST, #5483, 1:1000), IRF3 (Proteintech, #11312-1, 1:5000), and phospho-IRF3 (CST, #29047, 1:1000).

Techniques: CCK-8 Assay, Control, Solvent, Knockdown, Colony Assay, Migration, Transwell Assay